Cargando…
Breast cancer therapy affects the expression of antineonatal Nav1.5 antibodies in the serum of patients with breast cancer
Neonatal Nav1.5 (nNav1.5) is the alternative splice variant of Nav1.5 and it has been widely associated with the progression of breast cancer. The immunological context of nNav1.5 with respect to breast cancer metastases remains unexplored. The presence of antibodies against nNav1.5 may highlight th...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751336/ https://www.ncbi.nlm.nih.gov/pubmed/33376541 http://dx.doi.org/10.3892/ol.2020.12369 |